Arsenal of antibiotics not being restocked - Drug companies are abandoning the antibacterial busine
• godlikeproductions.comDrug companies are abandoning the antibacterial business, citing high development costs, low return on investment and, increasingly, a nearly decade-long stalemate with the Food and Drug Administration over how to bring new antibiotics to market.
